These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27837518)

  • 1. Molecular Detection of Resistance to Echinocandins.
    Posteraro B; Vella A; De Carolis E; Sanguinetti M
    Methods Mol Biol; 2017; 1508():413-421. PubMed ID: 27837518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Detection of Resistance to Azole Components.
    Posteraro B; Vella A; De Carolis E; Sanguinetti M
    Methods Mol Biol; 2017; 1508():423-435. PubMed ID: 27837519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical perspectives on echinocandin resistance among Candida species.
    Shields RK; Nguyen MH; Clancy CJ
    Curr Opin Infect Dis; 2015 Dec; 28(6):514-22. PubMed ID: 26524326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.
    Perlin DS
    Drugs; 2014 Sep; 74(14):1573-85. PubMed ID: 25255923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.
    Garnaud C; Botterel F; Sertour N; Bougnoux ME; Dannaoui E; Larrat S; Hennequin C; Guinea J; Cornet M; Maubon D
    J Antimicrob Chemother; 2015 Sep; 70(9):2556-65. PubMed ID: 26017039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.
    Garcia-Effron G; Katiyar SK; Park S; Edlind TD; Perlin DS
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2305-12. PubMed ID: 18443110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.
    Biswas C; Chen SC; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
    Clin Microbiol Infect; 2017 Sep; 23(9):676.e7-676.e10. PubMed ID: 28344162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong
    Schell WA; Jones AM; Garvey EP; Hoekstra WJ; Schotzinger RJ; Alexander BD
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.
    Morales-López S; Dudiuk C; Vivot W; Szusz W; Córdoba SB; Garcia-Effron G
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.
    Klotz U; Schmidt D; Willinger B; Steinmann E; Buer J; Rath PM; Steinmann J
    Mycoses; 2016 May; 59(5):312-8. PubMed ID: 26806376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients.
    Prigent G; Aït-Ammar N; Levesque E; Fekkar A; Costa JM; El Anbassi S; Foulet F; Duvoux C; Merle JC; Dannaoui E; Botterel F
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection.
    Shields RK; Nguyen MH; Press EG; Cumbie R; Driscoll E; Pasculle AW; Clancy CJ
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7465-70. PubMed ID: 26392494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?
    Fekkar A; Dannaoui E; Meyer I; Imbert S; Brossas JY; Uzunov M; Mellon G; Nguyen S; Guiller E; Caumes E; Leblond V; Mazier D; Fievet MH; Datry A
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1489-96. PubMed ID: 24715154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.
    Pfaller MA; Messer SA; Rhomberg PR; Borroto-Esoda K; Castanheira M
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Case of Echinocandin-Resistant Candida albicans in Korea.
    Park MS; Park JE; Song DJ; Huh HJ; Park S; Kang CI; Shin JH; Lee NY
    Ann Lab Med; 2017 Nov; 37(6):556-558. PubMed ID: 28841000
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.
    Thompson GR; Wiederhold NP; Vallor AC; Villareal NC; Lewis JS; Patterson TF
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3783-5. PubMed ID: 18676885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.